AnaptysBio Inc (ANAB) is around the bottom of the Biotechnology industry according to InvestorsObserver. ANAB received an overall rating of 21, which means that it scores higher than 21 percent of all stocks. AnaptysBio Inc also achieved a score of 10 in the Biotechnology industry, putting it above 10 percent of Biotechnology stocks. Biotechnology is ranked 27 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With AnaptysBio Inc Stock Today?
AnaptysBio Inc (ANAB) stock is trading at $23.80 as of 11:03 AM on Friday, Oct 16, an increase of $1.85, or 8.45% from the previous closing price of $21.94. The stock has traded between $22.00 and $24.44 so far today. Volume today is less active than usual. So far 187,181 shares have traded compared to average volume of 318,777 shares.
Click Here to get the full Stock Score Report on AnaptysBio Inc (ANAB) Stock.
